Hatteras Venture Advisors III, LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Hatteras Venture Advisors III, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Hatteras Venture Advisors III, LLC. Hatteras Venture Advisors III, LLC is a 10% Owner in PhaseBio Pharmaceuticals Inc ($PHAS) and a 10% Owner in Clearside Biomedical, Inc. ($CLSD).

Address: 280 S. MANGUM ST., SUITE 350 DURHAM 27701 NC

Companies in which Hatteras Venture Advisors III, LLC is an Insider

Clearside Biomedical, Inc.

Trading Symbol: CLSD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hatteras Venture Advisors III, LLC: 10% Owner
Holdings: 1,774,654 shares
Current Value: $12,866,242
Latest Transaction: Jan 19 2017
$CLSD Market Capitalization: $146.03M
$CLSD Previous Close: $7.25

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PhaseBio Pharmaceuticals Inc

Trading Symbol: PHAS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hatteras Venture Advisors III, LLC: 10% Owner
Holdings: 52,690 shares
Latest Transaction: Oct 24 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Hatteras Venture Advisors III, LLC

Sentiment: All, CLSD, PHAS

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.00226,06100
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0024,70900
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.00272,10700
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0040,42000
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0013,55800
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.00149,32000
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0094,87400

View all Hatteras Venture Advisors III, LLC insider transactions.